Moxifloxacin versus ethambutol in initial tuberculosis treatment.
Sellier
Pierre
P
Delcey
Veronique
V
Raskine
Laurent
L
Sanson-Le-Pors
Marie-José
MJ
Bergmann
Jean-François
JF
D000995:Antitubercular Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004977:Ethambutol / Q000627:therapeutic use*; D024841:Fluoroquinolones; D006801:Humans; D055118:Medication Adherence; D000077266:Moxifloxacin; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011804:Quinolines / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D004977:Ethambutol; D000077266:Moxifloxacin